Read more Meet VitroScan!

1 November 2025

In this video, Willemijn Vader explains how our ChemoPredict platform supports better treatment decisions.

Read more

Read more VitroScan awarded Kansen voor West grant to advance ex vivo tumor testing for next-generation immunotherapies

29 October 2025

VitroScan awarded 'Kansen voor West'-grant to advance ex vivo tumor testing for next-generation immunotherapies

Read more

Read more VitroScan's micro-tumor test accurately predicts chemotherapy response for ovarian cancer patients

9 September 2025

VitroScan is proud to announce the publication of a study showing its 3D ex vivo micro-tumor testing platform can accurately predict whether an ovarian cancer patient will respond to chemotherapy.

Read more